AI assistant
Sending…
Zymeworks Inc. — Director's Dealing 2023
Jul 1, 2023
32180_dirs_2023-06-30_9811d590-52db-44d5-83b5-93ec71ca2336.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Zymeworks Inc. (ZYME)
CIK: 0001937653
Period of Report: 2023-06-30
Reporting Person: Campoy Carlos (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-06-30 | Stock Option (Right to Buy) | $8.64 | A | 50000 | Acquired | 2033-06-29 | Common Stock (50000) | Direct |
Footnotes
F1: Stock options vest in 36 equal monthly installments starting one month after grant date of June 30, 2023.